Anita Pramoda - 01 Jun 2021 Form 4 Insider Report for Health Catalyst, Inc. (HCAT)

Role: Director
Signature: /s/ Daniel Orenstein, as Attorney-in-Fact
Issuer symbol: HCAT
Transactions as of: 01 Jun 2021
Net transactions value: -$339,879
Form type: 4
Filing time: 03 Jun 2021, 19:33:52 UTC
Previous filing: 28 May 2021
Next filing: 14 Jun 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HCAT	Common Stock	Options Exercise	$26,650	+2,500	+46%	$10.66	7,943	01 Jun 2021	Direct
transaction	HCAT	Common Stock	Sale	$133,910	-2,500	-31%	$53.56^*	5,443	01 Jun 2021	Direct	F1, F2
transaction	HCAT	Common Stock	Sale	$232,618	-4,348	-52%	$53.50^*	4,000	01 Jun 2021	By Omkara, LLC(3)	F1, F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	HCAT	Stock Option (Right to Buy)	Options Exercise	$0	-2,500	-100%	$0.000000^*	0	01 Jun 2021	Common Stock	2,500	$10.66	Direct	F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 4, 2021, in accordance with Rule 10b5-1.
F2	Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $53.37 to $54.00, inclusive.
F3	Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $53.09 to $53.98, inclusive. The Reporting Person will provide, upon request by the Issuer, a security holder of the Issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 2 and 3.
F4	The shares are held by Omkara, LLC and the Reporting Person wholly-owns and holds the voting and dispositive power of these shares.
F5	25% of the 20,000 shares underlying the options vested in an annual installment on April 27, 2018 and the remaining balance vested or will vest in equal monthly installments until the option vested in full on April 27, 2021.